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Abstracts / International Journal of Surgery 47 (2017) S15eS108 S103surgical treatment for urolithiasis between January 2010 and December
2011 allowing 5 year follow up.
Result: Preliminary data indicates no difference in stone size non-diabetic
vs diabetic population; (11.9 mm vs. 12.7 mm, p¼0.42). Diabetic patients
included in our study were signiﬁcantly older (65.6 vs 54, p¼0.001) and on
average had a worse kidney functionwith an eGFR (60 vs 68 p¼0.11) and a
serum creatinine of (103 vs 90, p ¼0.06). There was a greater proportion of
diabetic patients with a positive pre-operative MSU (42% vs 19%, p¼0.07).
We identify 14 diabetics vs 85 non-diabetics who have appropriate follow
up for one year, we ﬁnd that diabetics are more likely to recur in one year
than non-diabetics (46% vs 13%, p¼0.04)0775: REGULAR PSA TESTING IN GENERAL PRACTICE; DO WE SCREEN
AGAINST CURRENT UROLOGY CONSENSUS?
G. Munbauhal*1, A. Daoub 1, C. Lawton 2. 1 Shefﬁeld Teaching Hospitals,
Shefﬁeld, UK; 2Norwood Medical Centre, Shefﬁeld, UK.
The Prostate Cancer Risk Management Programme supports an informed
request for Prostate Speciﬁc Antigen(PSA) testing from asymptomatic men
aged 50, while current consensus rejects screeing due to overdiagnosis
and overtreatment. We audited current PSA-testing schedules and evalu-
ated whether asymptomatic patients receive adequate pre-test
counselling.
A cross-sectional analysis was done (EMIS Web database, Jul 2016) in a
single practice of 7800 patients, including all patients with regular repeat
PSA tests schedules (4-, 6- or 12-monthly). Indication, counselling, PSA
levels, diagnosis, and secondary care input were evaluated.
78 men with a median age 71(range 49-88) were identiﬁed (29 Prostate
Cancer, 24 Benign Prostatic Hypertrophy, 8 Unknown pathology, 7 Lower
Urinary Tract Symptoms, 5 “Raised PSA”, 2 Hypogonadism, 1 High Risk
Family History, 1 Overactive Bladder, 1 Chronic Prostatitis). Median initial
PSA was 6.9 ng/ml (range 0.01-60). 5 patients were asymptomatic (Age 
50) with no risk factors or known genitourinary pathology, but there was
no identiﬁed informed decision. Hospital shared care protocols guided
testing in 48 patients, with 5 patients accordingly referred back following
PSA rise.
While the current practice of phlebotomy-led test scheduling is suitable
for established pathological cases, a new patient pathway is needed to
ensure adequate patient counselling in focused PSA 'screening’.0810: FOLLOWUP OF PATIENTS WITH LOW RISK BLADDER CANCER IN A
TERTIARY REFERRAL UROLOGY UNIT: DOES INTRODUCTION OF NICE
GUIDANCE IMPROVE TIMELY DISCHARGE?
J. Clark, J. Pullan*, A. Sinclair. Stepping Hill Hospital, Manchester, UK.
Aim: To audit departmental practice of follow up of low risk bladder cancer
patients following introduction of NICE guidance.
Method: Patients with low risk bladder cancer (as classiﬁed by NICE)
undergoing follow up were identiﬁed using ﬂexible cystoscopy lists over 2
months. An audit of follow up schedules was completed against NICE
guidelines using clinic letters. A poster outlining the guidelines was dis-
played. After 3 months a re-audit was completed to assess change in
practice. Data were analysed using Excell.
Result: 30/146 (20.5%) patients with non-muscle invasive bladder cancer
were identiﬁed as low risk. 17/30 (57%) male and 13/30 (43%) female.
Median age was 75.8yrs. Initial resection histology included 3/30 (10%)
G1pTa and 17/30 (90%) G2pTa tumours. All were solitary and less than 3cm
in size. 0/30 (0%) of patients had biomarkers of cytology used for follow up.
7/30 (23%) of patients were discharged to primary care after 12 months of
follow up compared to 0/17 (0%) in the pre-intervention audit. 23/30
(76.5%) of patients were offered prolonged follow up compared to 17/17
(100%) pre-intervention.
Conclusion: Increasing departmental awareness of NICE guidance
improved discharge rates and reduced numbers of patients having pro-
longed inappropriate ﬂexible cystoscopy follow up.0850: LAPAROSCOPIC OFF-CLAMP PARTIAL NEPHRECTOMY FOR RENAL
TUMOURS WITH MODERATE TO HIGH R.E.N.A.L. NEPHROMETRY
SCORES
B. Mukhtar*, H. Randhawa, N. Grimes, R. Evans, W. El-Baroni, A. Thwaini.
Belfast City Hospital, Belfast, UK.
Aim: This study compares outcomes of Off-clamp partial nephrectomy
(OCPN) relative to Hilar-clamp partial nephrectomy (HCPN) for renal le-
sions with moderate to high R.E.N.A.L. nephrometry scores.
Method: Demographic & perioperative data, and tumour complexity,
calculated using the R.E.N.A.L. nephrometry scoring system, were collected
for all laparoscopic partial nephrectomy procedures performed by a single
surgeon between April 2014 and October 2016. OCPN cases with nephr-
ometry scores of intermediate (score 7-9) and high-complexity (score 10-
12) were compared against similarly scored HCPN cases. Adverse events,
the perioperative eGFR and oncological results were analysed. The Exact
Fischer and chi-square tests were used for statistical analyses.
Result: A total of 104 laparoscopic nephron-sparing procedures were
performed. 47 patients with a low nephrometry score (0-6) were excluded.
HCPN (n¼17) were used as a comparator (mean 25 min warm ischaemia
time). Estimated blood loss for OCPN (n¼40) and HCPN was 260mls and
471mls respectively (p<0.05). There was no signiﬁcant difference in terms
of reduction in eGFR, conversion-to-open, perioperative nephrectomy,
peri-operative urine leakage or positive margins.
Conclusion: OCPN appears to be a safe, effective and feasible option in the
management of selected cases of complex renal masses. Longer follow up
is needed to adequately assess the oncological outcome.0920: SKILLS ACQUISITION TREND AND OUTCOMES FROM LAPARO-
SCOPIC TO ROBOTIC ASSISTED RADICAL CYSTECTOMY
T. Yeong*, P. MacNeal, A. Mir, L. Samateh, J. Jaun, S.S. Kommu,
P.D. Rimington. Eastbourne District General Hospital, Eastbourne, UK.
Aim: To decipher the outcomes during the transition phase from Laparo-
scopic Radical Cystectomy (LRC) and Robot-Assisted Radical Cystectomy
(RARC) for Bladder Cancer (BC) using the template of a single experienced
minimally invasive urological surgeon.
Method: The ﬁnal 40 LRCs were compared with the ﬁrst 40 RARCs. The 80
patients underwent their respective procedures between October 2013
and October 2016 at a tertiary uro-oncological centre. Data was retro-
spectively evaluated. We compared the different parameters such as cys-
tectomy time, length of total hospital stay, lymph node dissection,
resection margins, in-patient complications and 30-day re-admission.
Data were analysed using SPSS Statistical Analysis Software.
Result: The median age for all patients is 70 (36 - 84), with median age of
71 (36 - 84) for RARCs and 70 (51 -82) for LRCs. Of total 80 patients, 62
(77.5%) were male and 18 (22.5%) were female. There were no signiﬁcant
differences in the rate of in-patient complications (p>1.00) and 30-day re-
admission (p>0.05) between those who had RARCs and LRCs.
Conclusion: The transition from laparoscopic to robotic platform was not
found to impact on cystectomy time, total length of hospital stay, lymph
node dissection, resection margins, in-patient complications and 30-day
re-admission rates. Current ﬁndings indicate the transition is safe.0930: THE VALUE OF REPEAT DIPSTICK URINALYSIS: EXPERIENCES
FROM AN ACUTE ADMISSIONS UNIT
C. Hardie*, N. Husnoo, C. Molokwu, J. Bolton. Bradford Teaching Hospitals
NHS Foundation Trust, Bradford, UK.
Background: Dipstick urinalysis is used to assess patients with urological
symptoms in emergency settings. Onwards referrals can depend on the
urinalysis results. At our hospital, patients referred from the emergency
department (ED) to the surgical assessment unit (SAU) often have their
urinalysis repeated. An audit was performed to determine if repeating the
urinalysis was justiﬁed.
Method: Prospective data was collected over one month. 52 patients who
had urinalysis performed in both departments were included and the re-
sults of their urine dips evaluated.
